Search

everythinglearnresearchcommunity

for

Search:↓

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Bimatoprost can help regrow eyelashes in people with trichotillomania.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Crescina® lotion helps reduce hair loss and increase hair growth in males with androgenetic alopecia.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

PRP injections safely increase hair density and thickness in androgenetic alopecia.

FUE megasession effectively treats severe hair loss with natural-looking results in one operation.

Metabolic syndrome reduces effectiveness of hair loss treatment.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

PRP injections help hair regrowth safely but may need more research.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Stem cells from hair follicles can safely treat hair loss.

5% minoxidil works better for hair growth than 1% minoxidil.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

PRP therapy and minoxidil combo works best for male hair loss.

Cynatine HNS improves hair and nail quality in 90 days.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.